Cannalyze

Database of Cannabis Strains, Compounds, and Potency

Health Tech & Life Sciences
Non Active, Jan 2020 ceased to operate
Pre-Funding Tel Aviv-Yafo Founded 2019
Total raised
Stage
Pre-Funding
Founded
2019
Headcount
2
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Cannalyze is developing an AI-based database of lab-tested cannabis compounds in order to provide consumers, caregivers, growers, and dispensaries with access to data on each product's unique potential effects. By making compound data accessible, Cannalyze will enable dispensaries to show their customers how different products can work for them, while providing growers with product feedback from consumers as well as other insights and tools to help them better understand their customers' needs. Cannalyze can also assist caregivers in prescribing the correct strains for their patients by providing information about each product's profile of compounds, potential effects, and consumption recommendations.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial Intelligence
Target customers
Commerce & RetailDistribution ChannelsBrick & MortarConsumersRecreational & LifestyleCannabisHealthcare & Life SciencesHealthcarePatientsProvidersLaboratories
Business model
B2BB2C

Tags

consumersdata-analyticscannabisalternative-medicinesearch-enginedecision-supportdigital-healthcareartificial-intelligencelaboratoriesmedical-cannabishealthcare-providers